I'm not too concerned about previous approvals for a number of reasons, but worse case scenario bene could just pull it off the market. I don't know how often iPPS is prescribed for thrombosis, but there are probably much better treatments out there for thrombosis right now than iPPS, so I have no doubt bene would rather supply it for OA. Who knows, maybe it's all included in the details of the exclusive supply agreement?
Ann: Paradigm AGM Presentation, page-44
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.015(6.52%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $116.0K | 491.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 33682 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |